CLIENT NEWS
- Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches26 January 2023
- Carbios strengthens Executive Committee in pivotal year for industrial and commercial development26 January 2023
- Destiny Pharma: US Center for Disease Control (CDC) and two major medical journals cite the importance of decolonization in preventing surgical site infections25 January 2023
- ONWARD Strengthens Leadership Team with Key Appointments in Clinical & Regulatory and Marketing23 January 2023
- Mainz Biomed Launches Corporate Health Program in Germany for ColoAlert18 January 2023
- ONWARD Announces Participation at Upcoming Events16 January 2023
- Carbios and Novozymes strengthen collaboration with long-term exclusive strategic partnership to secure worldwide leadership in biorecycling of PET12 January 2023
- Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension10 January 2023
- Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate Capital Group09 January 2023
- Proteros receives minority investment from private equity firm Inflexion09 January 2023